SCHEMBL17675462

SCHEMBL17675462

Nc1ccc2ncnc(Oc3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 3/20 0.51
EGFR P00533 3/20 0.51
KDR P35968 7/20 0.49
BRAF P15056 3/20 0.49
MAPK14 Q16539 3/20 0.49
TNNI3K Q59H18 3/20 0.49
GRM5 P41594 1/20 0.48
FLT3 P36888 3/20 0.45
PTGS1 P23219 2/20 0.44
CSF1R P07333 2/20 0.44
CLK2 P49760 1/20 0.42
IRAK1 P51617 1/20 0.42
NEK4 P51957 1/20 0.42
MAP4K2 Q12851 1/20 0.42
HIPK4 Q8NE63 1/20 0.42
SRPK1 Q96SB4 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
MAP3K20 Q9NYL2 1/20 0.42
STK17A Q9UEE5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675216 0.87 BTK (0.54) BTKEGFRKDRBRAFMAPK14
SCHEMBL17675293 0.86 EGFR (0.49) BTKEGFRKDRBRAFMAPK14
SCHEMBL17675433 0.85 KDR (0.59) KDRBRAFMAPK14TNNI3KGRM5
SCHEMBL17675352 0.84 EGFR (0.74) BTKEGFRKDRBRAFMAPK14
SCHEMBL17675332 0.84 BTK (0.70) BTKEGFRKDRCSF1R
SCHEMBL17675208 0.83 BTK (0.56) BTKEGFRKDRFLT3CSF1R
SCHEMBL17683706 0.81 BTK (0.59) BTKEGFRKDRBRAFMAPK14
SCHEMBL17683762 0.80 BTK (0.62) BTKEGFRKDRBRAFMAPK14
SCHEMBL28953974 0.79 PTGS1 (0.67) BTKEGFRGRM5PTGS1
SCHEMBL17683793 0.79 KDR (0.54) BTKEGFRKDRBRAFMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed